Caprock Group, Inc. Halozyme Therapeutics, Inc. Transaction History

Caprock Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$39.51 - $51.45 $276,174 - $359,635	-6,990 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$25.81 - $43.62 $180,411 - $304,903	6,990 New	6,990 $299,000
Q3 2020 Oct 29, 2020	SELL	$25.74 - $29.63 $208,494 - $240,003	-8,100 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$16.25 - $26.81 $131,625 - $217,161	8,100 New	8,100 $217,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.